EUVIMEDEUVIMED entdecken
Crossref

68Ga-OncoFAP-targeted PET/MRI for endometriosis assessment – initial results

J Brandt, P Backhaus, D Ventura, S Eltrop, P Schindler

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.04.2026 · 198 (S 01 S 01) · S92

DOI: 10.1055/s-0046-1817690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.04.2026. Verfasst von J Brandt und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zielsetzung Endometriosis is the leading cause for chronic pelvic pain and infertility in women of reproductive age. Conventional imaging methods may underestimate the extent of disease. Fibroblast activation protein (FAP) is highly expressed in remodeling endometrium and has been implicated in endometriosis lesions. This study investigates the feasibility of integrated FAP-targeted PET/MRI to improve endometriosis detection. Material und Methoden In this retrospective study, nine premenopausal women with confirmed endometriosis (test group) and nine premenopausal women without known endometriosis (reference group) underwent 68Ga-OncoFAP-directed PET/MRI or PET/CT (now distributed as 68Ga-BED003). Tracer uptake was assessed semi-quantitatively. Lesions were categorized based on a modified #ENZIAN segmentation. Clinical assessment or laparoscopy (when available) served as the reference standard. Statistical comparisons of tracer uptake and lesion counts between groups were performed using the Mann-Whitney U test. Ergebnisse In the test group, at least one endometriosis-related finding was identified in 6 of 7 patients who received PET/MRI when only MRI was evaluated, compared to all patients when combined PET/MRI was reviewed. In the test group, PET/MRI identified 45 of 91 segments (49.5%) as likely endometriotic compared with 17 of 91 segments (18.7%) with MRI alone. PET/CT and PET/MRI datasets showed focal tracer uptake in 44 of 108 segments (40.7%) in the test group, significantly higher than the 14 of 108 segments (13.0%) in the reference group (p

Zitieren

APA

Brandt, J., Backhaus, P., Ventura, D., Eltrop, S., & Schindler, P. (2026). 68Ga-OncoFAP-targeted PET/MRI for endometriosis assessment – initial results. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 198(S 01 S 01), S92. https://doi.org/10.1055/s-0046-1817690

Vancouver

Brandt J, Backhaus P, Ventura D, Eltrop S, Schindler P. 68Ga-OncoFAP-targeted PET/MRI for endometriosis assessment – initial results. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2026;198(S 01 S 01):S92. doi:10.1055/s-0046-1817690

BibTeX
@article{Brandt2026,
  author = {Brandt, J and Backhaus, P and Ventura, D and Eltrop, S and Schindler, P},
  title = {68Ga-OncoFAP-targeted PET/MRI for endometriosis assessment – initial results},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2026},
  volume = {198},
  number = {S 01 S 01},
  pages = {S92},
  doi = {10.1055/s-0046-1817690}
}
Kostenlos starten →